The dermatology devices studied and segmented in this report are as per their usage in the diagnosis and treatment of skin related disorders such as skin cancer (melanoma and non-melanoma), psoriasis, acne, scars, and others. The diagnostic devices analyzed are dermatoscopes, microscopes, imaging techniques such as MRI, CT and Optical Coherence Tomography (OCT) scanners. The total market for diagnostic devices was estimated to be $175 million in 2010, and is expected to grow at a CAGR of 7.3% from 2010 to 2015.

With increasing number of people suffering from skin disorders and more number of people opting for less invasive cosmetic surgeries, the demand for dermatology diagnostic and treatment devices is increasing. Of all the other treatment devices, LED light therapy devices account for the largest share due to the increasing incidences of skin diseases such as vascular lesion, pigment lesion, and skin cancer. The total market for treatment devices was estimated to be $3.6 billion in 2010.

Markets Covered

This research report categorizes the dermatology devices market into the following:

• Diagnostic devices: dermatoscopes, microscopes, and imaging techniques.
• Treatment devices: electrosurgical equipment, liposuction devices, cryotherapy devices, microdermabrasion, LED light therapy devices, and lasers.
  

The report provides market estimates and forecasts for the worldwide dermatology devices market in the U.S., Europe, Asia, and Rest of the World (ROW). In addition to market sizing and forecasts, the report offers a detailed analysis of the market trends, opportunities, and the factors influencing the growth of each segment of the dermatology devices market. The report also draws a competitive landscape, analyzing core competencies of major players and strategies adopted to expand their market presence.

Stakeholders

The targeted audience for this report includes:

• Dermatology devices manufacturers
• Dermatology devices distributors
• Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
• Various research and consulting companies
• Various research associations related to dermatology devices

Research methodology

• Market information was obtained through secondary research on company websites and news articles.
• Market size of the segments was calculated using the bottom-up approach.
• Market revenues of key players were determined by primary and secondary research, which included study of the annual reports of the company and interviews with key opinion leaders, CEOs, directors, and managers.

TABLE OF CONTENTS   
   
Executive Summary   
 Market Overview   

1 Introduction  
  
2 Summary  

3 Market Overview   
  3.1 Introduction 
  3.2 Market Segmentation 
  3.3 Product Market Share Analysis 
  3.4 Patents Analysis 
  3.5 Comparative Analysis 
  3.6 Driving Factor Analysis 
       3.6.1 Supply side drivers
             3.6.1.1 Technical advances boost market growth
       3.6.2 Demand side drivers
       3.6.2.1 Rising incidence of skin disorders
       3.6.3 Threats
             3.6.3.1 Competitive pricing from low cost manufacturers
       3.6.4 Opportunities
             3.6.4.1 Huge untapped population
  3.7 Winning Imperatives and Burning Issues 
  3.8 Dermatology injectables 
       3.8.1 Dermal fillers
       3.8.2 Muscle relaxants
  3.9 Alternate Devices - Magnifiers 
  3.10 Present & Future Technologies 
       3.10.1 Teledermatology
       3.10.2 Nanodermatology

4 Dermatology Diagnostic Devices Market  
  4.1 Introduction 
  4.2 Dermatoscope 
       4.2.1 Drivers
             4.2.1.1 High incidence of melanoma and non-melanoma skin cancer
             4.2.1.2 Technological advancements
             4.2.1.3 Low cost/ utility ratio
             4.2.1.4 Product differentiation to drive growth and obviate threat of substitutes
       4.2.2 Restraints
             4.2.2.1 High threat from substitutes
       4.2.3 Opportunities
             4.2.3.1 Increased activities for global penetration
  4.3 Microscopes 
  4.4 Imaging Techniques 
       4.4.1 Drivers & restraints
             4.4.1.1 Imaging techniques as the confirmatory diagnostic tests
             4.4.1.2 Increased investments & other initiatives
             4.4.1.3 Hand-held devices increase convenience for users
             4.4.1.4 Limited patient base
       4.4.2 OPPORTUNITIES
             4.4.2.1 Continuous technological upgradation
             4.4.2.2 Per scan fee lesser in emerging economies
       4.4.3 Optical coherence tomography scanner
             4.4.3.1 Drivers & opportunities
                     4.4.3.1.1 New technological development for skin cancer diagnostics
                     4.4.3.1.2 Lack of competition in the high potential market

5 Dermatology Treatment Devices Market  
  5.1 Introduction 
  5.2 Electrosurgical Equipment 
  5.3 Liposuction Devices 
  5.4 Microdermabrasion 
  5.5 Cryotherapy Devices 
  5.6 Led Light Therapy Devices 
  5.7 Lasers 
      5.7.1 Factors influencing the market
            5.7.1.1 Increasing prevalence rates of indications boost demand
            5.7.1.2 Increasing demand for devices with less downtime
            5.7.1.3 Threat from low quality device manufacturers
      5.7.2 Types of lasers
            5.7.2.1 Carbon-dioxide lasers
            5.7.2.2 ND-YAG lasers
            5.7.2.3 Pulsed dye laser
            5.7.2.4 Diode laser
            5.7.2.5 Argon laser
            5.7.2.6 Ruby laser
            5.7.2.7 Erbium-yag laser
            5.7.2.8 Intense pulse light
      5.7.3 Major applications of lasers
            5.7.3.1 Hair removal
            5.7.3.2 Skin rejuvenation
            5.7.3.3 Pigmented lesions
            5.7.3.4 Acne
            5.7.3.5 Vascular lesions
            5.7.3.6 Wrinkle removal
            5.7.3.7 Skin resurfacing
            5.7.3.8 Psoriasis
            5.7.3.9 Tattoo removal

6 GEOGRAPHIC ANALYSIS  
  6.1 Introduction 
  6.2 U.S. 
  6.3 Europe 
  6.4 Asia 
  6.5 RoW 

7 Competitive Landscape  
  7.1 Introduction 

8 Company Profiles  
  8.1 ALMA LASERS LTD 
      8.1.1 Overview 
      8.1.2 Products
      8.1.3 Strategy
      8.1.4 Developments
  8.2 AGILENT TECHNOLOGIES INC 
      8.2.1 Overview  
      8.2.2 Financials
      8.2.3 Products
      8.2.4 Strategy
      8.2.5 Developments
  8.3 AMBICARE HEALTH LTD 
      8.3.1 Overview  
      8.3.2 Products
      8.3.3 Strategy
      8.3.4 Developments
  8.4 AMD GLOBAL TELEMEDICINE INC 
      8.4.1 Overview  
      8.4.2 Products
      8.4.3 Strategy
      8.4.4 Developments
  8.5 APPLISONIX LTD 
      8.5.1 Overview  
      8.5.2 Products
      8.5.3 Strategy
      8.5.4 Developments
  8.6 BIOLITEC AG 
      8.6.1 Overview  
      8.6.2 Financials
      8.6.3 Products
      8.6.4 Strategy
      8.6.5 Developments
  8.7 BRUKER CORP 
      8.7.1 Overview  
      8.7.2 Financials
      8.7.3 Products
      8.7.4 Strategy
      8.7.5 Developments
  8.8 CARL ZEISS 
      8.8.1 Overview  
      8.8.2 Financials
      8.8.3 Products
      8.8.4 Strategy
      8.8.5 Developments
  8.9 CUTERA INC 
      8.9.1 Overview  
      8.9.2 Products
      8.9.3 Strategy
      8.9.4 Developments
  8.10 CYNOSURE INC 
      8.10.1 Overview  
      8.10.2 Financials
      8.10.3 Products
      8.10.4 Strategy
      8.10.5 Developments
  8.11 ELLIPSE A/S 
      8.11.1 Overview  
      8.11.2 Products
      8.11.3 Strategy
      8.11.4 Developments
  8.12 FEI COMPANY 
      8.12.1 Overview  
      8.12.2 Financials
      8.12.3 Products
      8.12.4 Strategy
      8.12.5 Developments
  8.13 FOTOFINDER SYSTEMS GMBH 
      8.13.1 Overview  
      8.13.2 Products
      8.13.3 Strategy
      8.13.4 Developments
  8.14 GE HEALTHCARE 
      8.14.1 Overview  
      8.14.2 Financials
      8.14.3 Products
      8.14.4 Strategy
      8.14.5 Developments
  8.15 GENESIS BIOSYSTEMS 
      8.15.1 Overview  
      8.15.2 Products
      8.15.3 Strategy
      8.15.4 Developments
  8.16 HOYA CONBIO 
      8.16.1 Overview  
      8.16.2 Products
      8.16.3 Strategy
      8.16.4 Developments
  8.17 IRIDEX CORP 
      8.17.1 Overview  
      8.17.2 Products
      8.17.3 Financials
      8.17.4 Strategy
      8.17.5 Developments
  8.18 LEICA MICROSYSTEMS 
      8.18.1 Overview  
      8.18.2 Products
      8.18.3 Strategy
      8.18.4 Developments
  8.19 LUCID INC 
      8.19.1 Overview  
      8.19.2 Products
      8.19.3 Strategy
      8.19.4 Developments
  8.20 LUMENIS LTD 
      8.20.1 Overview  
      8.20.2 Financials
      8.20.3 Products
      8.20.4 Strategy
      8.20.5 Developments
  8.21 MICHELSON DIAGNOSTICS LTD 
      8.21.1 Overview  
      8.21.2 Products
      8.21.3 Strategy
      8.21.4 Developments
  8.22 NIKON CORP 
      8.22.1 Overview  
      8.22.2 Financials
      8.22.3 Products
      8.22.4 Strategy
      8.22.5 Developments     
  8.23 OLYMPUS CORP 
      8.23.1 Overview  
      8.23.2 Financials
      8.23.3 Products
      8.23.4 Strategy
      8.23.5 Developments
  8.24 PALOMAR MEDICAL TECHNOLOGIES INC 
      8.24.1 Overview  
      8.24.2 Financials
      8.24.3 Products
      8.24.4 Strategy
      8.24.5 Developments
  8.25 PHOTOMEDEX INC 
      8.25.1 Overview  
      8.25.2 Products
      8.25.3 Strategy
      8.25.4 Developments
  8.26 SOLTA MEDICAL INC 
      8.26.1 Overview  
      8.26.2 Financials
      8.26.3 Products
      8.26.4 Strategy
      8.26.5 Developments
  8.27 SYNERON MEDICAL LTD 
      8.27.1 Overview  
      8.27.2 Financials
      8.27.3 Products
      8.27.4 Strategy
      8.27.5 Developments
  8.28 TOSHIBA MEDICAL SYSTEMS 
      8.28.1 Overview  
      8.28.2 Products
      8.28.3 Strategy
      8.28.4 Developments
  8.29 OTHERS 
      8.29.1 BOSTON SCIENTIFIC CORP
             8.29.1.1 Overview
             8.29.1.2 Products
      8.29.2 CONMED CORP
             8.29.2.1 Overview
             8.29.2.2 Financials
             8.29.2.3 Products
      8.29.3 C.R. BARD INC
             8.29.3.1 Overview
             8.29.3.2 Financials
             8.29.3.3 Products
      8.29.4 HEINE OPTOTECHNIK GMBH & CO. KG
             8.29.4.1 Overview
             8.29.4.2 Products

APPENDIX   
 U.S. Patents  
 Europe patents  
 Japan patents  
 Wipo patents  

LIST OF TABLES 
 
1 Global Dermatology Devices Market, by Segments, 2008 – 2015 ($Million)
2 Types of Dermal Fillers
3 Dermal Fillers Market, by Geography, 2008 – 2015 ($Million)
4 Dermal Fillers Number of Procedures (In Million)
5 Muscle Relaxants Market, by Geography, 2008 – 2015 ($Million)
6 Muscle Relaxants Number of Procedeures (In Million)
7 Global Diagnostic Devices Market, by Products, 2008 – 2015 ($Million)
8 Global Dermatoscope Market, by Products, 2008 – 2015 ($Million)
9 Dermatoscope Market, by Geography, 2008 – 2015 ($Million)
10 Microscope Market, by Geography, 2008 – 2015 ($Million)
11 Global Imaging Techniques Market, by Products, 2008 – 2015 ($Million)
12 Imaging Techniques Market, by Geography, 2008 – 2015 ($Million)
13 Optical Coherence Tomography Scanners Market, by Geography, 2008 – 2015 ($Million)
14 Global Dermatology Devices Market, by Treatments, 2008 – 2015 ($Million)
15 Electrosurgical Equipment Market, by Geography, 2008 – 2015 ($Million)
16 Liposuction Devices Market, by Geography, 2008 – 2015 ($Million)
17 Microdermabrasion Market, by Geography, 2008 – 2015 ($Million)
18 Cryotherapy Devices Market, by Geography, 2008 – 2015 ($Million)
19 Led Light Therapy Devices Market, by Geography, 2008 – 2015 ($Million)
20 Global Lasers Market, by Technology, 2008 – 2015 ($Million)
21 Lasers Market, by Geography, 2008 – 2015 ($Million)
22 Carbon-Dioxide Lasers Market, by Geography, 2008 – 2015 ($Million)
23 Nd-Yag Lasers Market, by Geography, 2008 – 2015 ($Million)
24 Pulsed Dye Laser Market, by Geography, 2008 – 2015 ($Million)
25 Diode Laser Market, by Geography, 2008 – 2015 ($Million)
26 Argon Laser Market, by Geography, 2008 – 2015 ($Million)
27 Ruby Laser Market, by Geography, 2008 – 2015 ($Million)
28 Erbium-Yag Laser Market, by Geography, 2008 – 2015 ($Million)
29 Intense Pulse Light Market, by Geography, 2008 – 2015 ($Million)
30 Laser Hair Removal Devices, by Geography, 2008 – 2015 ($Million)
31 Laser Skin Rejuvenation Devices, by Geography, 2008 – 2015 ($Million)
32 Laser Pigmented Lesions Devices Market, by Geography, 2008 – 2015 ($Million)
33 Laser Acne Devices Market, by Geography, 2008 – 2015 ($Million)
34 Laser Vascular Lesions Devices Market, by Geography, 2008 – 2015 ($Million)
35 Laser Wrinkle Removal Devices Market, by Geography 2008 – 2015 ($Million)
36 Laser Skin Resurfacing Devices Market, by Geography, 2008 – 2015 ($Million)
37 Laser Psoriasis Devices Market, by Geography, 2008 – 2015 ($Million)
38 Laser Tattoo Removal Devices Market, by Geography, 2008 – 2015 ($Million)
39 Dermatology Devices Market, by Geography, 2008 – 2015 ($Million)
40 U.S.: Dermatology Diagnostic Devices Market, by Products, 2008 – 2015 ($Million)
41 U.S.: Dermatology Treatment Devices Market, by Products, 2008 – 2015 ($Million)
42 Europe: Dermatology Diagnostic Devices Market, by Products, 2008 – 2015 ($Million)
43 Europe: Dermatology Treatment Devices, by Products, 2008 – 2015 ($Million)
44 Asia: Dermatology Diagnostic Devices Market, by Products, 2008 – 2015 ($Million)
45 Asia: Dermatology Treatment Devices Market, by Products, 2008 – 2015 ($Million)
46 Row: Dermatology Diagnostic Devices Market, by Products, 2008 – 2015 ($Million)
47 Row Dermatology Treatment Devices, by Products, 2008 – 2015 ($Million)
48 New Product Developments
49 Agreements & Collaborations
50 Mergers & Acquisitions
51 Approvals
52 Agilent Technologies Revenues ($Million)
53 Agilent Technologies Revenues, by Segments ($Million)
54 Biolitec Revenues and R&D Expenditure (Euro Million)
55 Biolitec Revenues, by Segments (Euro Million)
56 Biolitec Revenues, by Geography (Euro Million)
57 Bruker Revenues and R&D Expenditure ($Million)
58 Bruker Revenues, by Segments ($Million)
59 Carl Zeiss Revenues & R&D Expenditure ($Thousand)
60 Carl Zeiss Revenues, by Geography ($Thousand)
61 Cutera Revenues and Research and Development ($Million)
62 Cynosure Revenues and R&D Expenditure ($Million)
63 Cynosure Revenues, by Geography ($Million)
64 Fei Revenues and & R&D Expenditure ($Million)
65 Fei Revenues, by Segments ($Million)
66 Ge Healthcare Sales ($Million)
67 Iridex Revenues and R&D Expenditure ($Million)
68 Iridex Revenues, by Segments ($Million)
69 Iridex Revenues, by Geography ($Million)
70 Lumenis Revenues and R&D Expenditure ($Million)
71 Lumenis Revenues, by Segments ($Million)
72 Lumenis Revenues, by Geography ($Million)
73 Nikon Revenues and R&D Expenditure ($Thousand)
74 Nikon Revenues, by Segments ($Thousand)
75 Nikon Revenues, by Geography ($Thousand)
76 Olympus Revenues and R&D Expenediture ($Million)
77 Olympus Revenues, by Segments ($Million)
78 Olympus Revenues, by Geography ($Million)
79 Palomar Revenues, by Segments ($Million)
80 Palomar Revenues, Geography ($Million)
81 Solta Medical Revenues and R&D Expenses ($Million)
82 Syneron Medical Revenues and R&D Expenditure ($Million)
83 Syneron Medical Revenues, by Geography ($Million)
84 Conmed Net Sales and R&D Expenditure ($Million)
85 C.R.Bard Net Sales and R&D Expenditure ($Million)
86 C.R.Bard Net Sales, by Segments ($Million)

LIST OF FIGURES   
 
1 Dermatology Diagnostic & Treatment Devices Sales ($Million)
2 Dermatology Devices: Market Segmentation
3 Market Share Analysis of Diagnostic Devices (2010)
4 Market Share Analysis of Treatment Devices (2010)
5 Patent Analysis – by Segments
6 Patent Analysis – by Assignee
7 Global Dermatology Devices Market: Competitive Landscape
8 Driving Factor Analysis
9 Incidence Rate of Various Skin Diseases in % (2009) 
10 Major Growth Strategies in the Dermatology Devices Market (January 2008 – February 2011)

Worldwide Dermatology Devices Market (2010-2015)

Dermatology devices assist in enhancing and improving the patient’s skin conditions. With the use of dermatological devices such as dermatoscopes, microscopes, and imaging techniques, the dermatologists are able to identify the skin disorders at an early stage. Factors driving the demand for dermatological devices are the desire for youthful appearance, increasing incidence rates of skin diseases, increasing trend towards non-invasive aesthetic procedures, and technological advancements. People are becoming more conscious about their appearance and are aware of the skin disorders caused due to exposure to sun. Dermatological devices are used for the treatment of various skin indications such as scars, psoriasis, acne, skin cancer, varicose veins, pigment and vascular lesions.

Dermatology devices are used by dermatologists and surgeons for diagnosing the skin disorders. Dermatological devices increase the accuracy level of dermatologists for diagnosing the type of skin disorder. This report analyzes the dermatology devices market in two segments; i.e. diagnostic devices and treatment devices. Treatment devices form a major segment of the dermatology devices market. This segment consists of devices such as electrosurgical equipments, liposuction devices, LED light therapy devices, microdermabrasion, and various types of lasers such as carbon-dioxide lasers, argon lasers, diode laser, Nd:YAG (neodymium-doped yttrium aluminium garnet) laser, and intense pulse light (IPL). Of all the treatment devices, segmented LED light therapy devices account for the largest share.

With increasing number of people suffering from skin disorders and more number of people opting for less invasive cosmetic surgeries, the demand for dermatology diagnostic and treatment devices is increasing. Of all the other treatment devices, LED light therapy devices account for the largest share due to the increasing incidences of skin diseases such as vascular lesion, pigment lesion, and skin cancer. The total market for treatment devices was estimated to be $3.6 billion in 2010.

Factors driving the growth of the U.S. dermatology devices market are: increasing number of people getting affected by various skin disorders such as acne and harmful effects to skin due to exposure to sun. Thus, with the increasing need for skin diagnosis of diseases such as melanoma and non-melanoma skin cancers, dermatologists are making use of dermatological devices for skin analysis. In the U.S., there are increasing numbers of people suffering from various skin diseases such as psoriasis and non-melanoma skin cancer. Around 3.5 million people are suffering from non-melanoma skin disease, and 1/5th of the total population above the age of 70 years suffers from the same disease and more than 5.8 million people suffer from psoriasis, a chronic skin disorder. Thus, the increasing number of people getting affected by these diseases influences the growth of dermatological devices.